INS and diabetes mellitus: Several popular classes of oral diabetes therapies on the market include sulfonylureas, peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, metformin and so forth [7,8], which lower glucose by increasing glucose metabolism either via enhanced insulin secretion or improved insulin sensitivity.